Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 12:14 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 145–168 of 338 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Comparative Effectiveness Study Clear all

Conditions: Head Lice, Pediculosis Capitis
Interventions: X92001752, RID Super Max Solution, Nix Crème, Pouxit Végétal; Device · Drug
Lead sponsor: Oystershell NV; Industry
Eligibility: 1 Year and older
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Plantation, Florida

Conditions: Non-small Cell Lung Cancer, Squamous Lung Dysplasia
Interventions: placebo, inositol; Other · Drug
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 45 Years to 79 Years
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 3
States / cities: Scottsdale, Arizona • Rochester, Minnesota • Albuquerque, New Mexico

Conditions: Adenomas
Interventions: Endoscopic Mucosal Resection of large colon polyps (greater than or equal to 20 mm in size); Procedure
Lead sponsor: Cosmo Technologies Ltd; Industry
Eligibility: 18 Years and older
Enrollment: 226 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 3
States / cities: Jacksonville, Florida • Indianapolis, Indiana • Kansas City, Missouri

Conditions: Hepatocellular Carcinoma
Interventions: Nivolumab, Sorafenib, Ipilimumab, Cabozantinib; Biological · Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 657 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2024
U.S. locations: 10
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Pensacola, Florida + 7 more

Conditions: Type 2 Diabetes Mellitus, Obesity
Interventions: Roux-en-Y Gastric Bypass Surgery, Laparoscopic Adjustable Gastric Banding, Lifestyle Weight Loss Intervention; Procedure · Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 25 Years to 55 Years
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Bipolar Disorder
Interventions: Not listed
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Cutaneous Lupus
Interventions: 532nm laser, 1064nm laser, Topical corticosteroid; Device · Drug
Lead sponsor: David Weinstein; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Active, Symptomatic Blepharitis
Interventions: ISV-305, Vehicle; Drug · Other
Lead sponsor: Sun Pharmaceutical Industries Limited; Industry
Eligibility: 1 Year and older
Enrollment: 558 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Newport Beach, California

Conditions: Cardiac Rehabilitation
Interventions: Referral to home-based cardiac rehab, Referral to center-based cardiac rehab; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 1,154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Hypertension
Interventions: Chlorthalidone, Hydrochlorothiazide; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years to 90 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Bipolar Disorder
Interventions: Lithium, Quetiapine; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 68 Years
Enrollment: 482 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 11
States / cities: Birmingham, Alabama • Stanford, California • Boston, Massachusetts + 8 more

Conditions: HIV, AIDS
Interventions: Kaletra (drug); Drug
Lead sponsor: Lampiris, Harry W., M.D.; Individual
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2005
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Community-Acquired Bacterial Pneumonia (CABP)
Interventions: Nafithromycin 800 mg 3 days, Nafithromycin 800 mg 5 days, Moxifloxacin 400 mg; Drug
Lead sponsor: Wockhardt; Industry
Eligibility: 18 Years and older
Enrollment: 231 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 6
States / cities: Miami, Florida • Miami Lakes, Florida • Bedford, Massachusetts + 1 more

Conditions: Androgenetic Alopecia
Interventions: ARTAS™ System, Manual Hair Harvest; Device · Procedure
Lead sponsor: Restoration Robotics, Inc.; Industry
Eligibility: 30 Years to 59 Years · Male only
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Palo Alto, California • Walnut Creek, California

Conditions: Liver Transplant, Hepatitis C
Interventions: Pegasys, Copegus; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 19 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Wounds
Interventions: MIST Therapy, Vacuum Assisted Closure, MIST Therapy and Negative Pressure Wound Therapy; Device
Lead sponsor: Celleration, Inc.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Mesa, Arizona

Conditions: Adolescent Alcohol Use
Interventions: Brief Motivational Interviewing-based Alcohol Intervention, Smartphone App-delivered Mindfulness Training; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 12 Years to 17 Years
Enrollment: 1,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 13
States / cities: Baltimore, Maryland • Belcamp, Maryland • Bowie, Maryland + 6 more

Conditions: Breast Cancer
Interventions: Screening digital mammography, Screening digital breast tomosynthesis, Screening breast magnetic resonance imaging, Diagnostic mammography, Pre-operative breast magnetic resonance imaging; Other
Lead sponsor: University of California, Davis; Other
Eligibility: 18 Years to 89 Years · Female only
Enrollment: 1,341,172 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 7
States / cities: Davis, California • San Francisco, California • Chicago, Illinois + 4 more

Conditions: Iron Deficiency Anaemia, Chronic Kidney Disease
Interventions: FCM (Ferric carboxymaltose) high ferritin target, FCM (Ferric carboxymaltose) low ferritin target, Oral Iron (Ferrous sulphate); Drug
Lead sponsor: Vifor Pharma; Industry
Eligibility: 18 Years and older
Enrollment: 626 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Wilmington, North Carolina

Conditions: Invasive Mucormycosis, Invasive Aspergillosis
Interventions: Isavuconazonium sulfate; Drug
Lead sponsor: Astellas Pharma Global Development, Inc.; Industry
Eligibility: 1 Year to 17 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 5
States / cities: Los Angeles, California • Orange, California • Washington D.C., District of Columbia + 1 more

Conditions: Multiple Myeloma
Interventions: Elranatamab, Standard of care; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 508 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Pneumonia, Pneumocystis Carinii, HIV Infections
Interventions: Pentamidine isethionate; Drug
Lead sponsor: Fisons; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Rochester, New York

Conditions: POSTOPERATIVE PAIN
Interventions: Surgical TAP block, Conventional TAP block, 0.5% ropivacaine; Procedure · Drug
Lead sponsor: Maimonides Medical Center; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Heart Failure
Interventions: Baseline questionnaires, Post-questionnaire; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Stanford, California

Search by objective public record fields.

A Clinical Trial to Evaluate Efficacy and Safety of a New Suffocating Head Lice Product.

Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia

Safety Study of SIC 8000 in Subjects Undergoing Endoscopic Mucosal Resection (EMR) of Colonic Lesions Equal to or Larger Than 2 cm

An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer

The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes

Effectiveness of Two Self Assessment Tools: KIOS-Bipolar or eMoods

Study of the Efficacy of 532nm Laser and 1064 nm Laser in the Treatment of Cutaneous Lupus Erythematous Versus Topical Corticosteroids Alone

Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects

The Healthy Heart Study

EBMtrialcentral- Comparing Initial Diuretic Therapies Using a Collaborative Network

Comparative Effectiveness Study for Bipolar Disorder

High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease

Phase II Study of Oral Nafithromycin in CABP

Computer-Assisted Versus Manual Hair Harvest Comparative Study

Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C

Comparative Effectiveness Study of MIST Therapy Versus Negative Pressure Wound Therapy

Brief Motivational Interviewing +/- Mindfulness Training for Adolescent Alcohol Use in Pediatric Primary Care

Assessing Breast Density's Value in Imaging - A Comparative Effectiveness Study

Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)

A Study to Evaluate Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis (IA) or Invasive Mucormycosis (IM) in Pediatric Participants

A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma

The Safety and Effectiveness of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Who Have Had PCP Before

Comparative Study of Two Different Techniques to Perform TAP-blocks

A Comparative Study on the Effectiveness of Video vs Text-Based Education in Heart Failure